- English
- Français Canadien
- 日本語
With global revenues expected to reach $290 billion by 2030, oncology is one of the most important development areas in our industry, with the potential to help the over 16 million people (about the population of New York) in the US living with cancer today.
True therapeutic alignment in drug development allows industry leaders to leverage experience, insights and capabilities and offer thoughtful, integrated solutions. In pursuing new products to help cancer patients see better outcomes, there are inherent, unique challenges and considerations.
Find us at Booth #17103 or schedule to meet with us at ASCO to discuss how you can mitigate challenges in your oncology pipeline.
Additional Resources
詳細に興味がおありですか？Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
Capabilities
Syneos Health Oncology and Hematology
インサイト
欧州におけるオンコロジー製品の上市に向けたGo-to-Market戦略の最適化
The Muscle Behind Improved Clinical Outcomes in Oncology
Meeting Communication Challenges Unique to CAR-T Therapies
